健康新聞

Automatically tracked news coverage for the drugs and predicted indications on this site.

All coverage

About the Developer

This platform is developed and operated by 藥提醒科技有限公司 (yao.care, company registration number 83620786, 12F, No. 220, Sec. 2, Taiwan Blvd., West Dist., Taichung City, Taiwan).

DkTxGNN is the Denmark site of the company’s “TxGNN Drug Repurposing” product line. The same system is deployed across 30 countries and regions, each named {CC}TxGNN (JpTxGNN, UsTxGNN, DETxGNN, and so on) at {cc}txgnn.yao.care. Product overview: https://www.yao.care/medical/txgnn/.

The TxGNN model itself was developed by the Zitnik Lab at Harvard Medical School and published in Nature Medicine. This platform is the production system 藥提醒科技有限公司 built on top of that model, covering national drug-registration data integration, dual knowledge-graph and deep-learning prediction, PubMed / ClinicalTrials evidence grading, and SMART on FHIR electronic health record integration.

Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.

Reviewed by: 藥提醒科技有限公司 (yao.care)